A previous study has demonstrated that only one in 30,000 or less CD4+ T-cells in peripheral blood from patients with recent-onset T1D is GAD65-specific [23], and activation and in vitro amplification of the GAD65-specific T-cells is crucial for detection. The gene discussed is GAD2; the disease is type 1 diabetes mellitus.